pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 6·1 min read
save

Dr. Glaucomflecken protests corporate staffing of PeaceHealth emergency department in Oregon

May 6, 2026·read at STAT ↗Negative

Dr. Glaucomflecken, the online persona of physician Will Flanary, hosts the First Opinion Podcast where he blends humor with health‑care commentary.

He has become a vocal critic of PeaceHealth’s plan to replace the long‑standing community physicians in Eugene’s emergency department with a corporate staffing group.

Flanary argues that hospital administrators, insurers and private‑equity firms often hide such moves because they prioritize financial gains over patient care and try to keep the changes out of public view.

The discussion appeared on a recent podcast episode that examined misinformation on social media and the growing corporate influence in medicine.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Dr. Glaucomflecken wants to make a stink”

read at STAT ↗
516 words · retrieved May 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Alzheimer's DiseaseCardiologyOphthalmology

related stories

  • May 7Opinion: Eugene Braunwald, ‘father of modern cardiology,’ told me he had two dreams. One came trueSTAT
  • Dec 23Fierce Biotech Layoff Tracker 2026: Enlivex excises 60%; Eyepoint halves headcountFierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 18Ebola cases increase almost 40% in a week as death toll passes 200STAT
  • Jun 17UniQure to file gene therapy for approval, reflecting major shifts at FDABioPharma Dive